Drug
D1109 | tenonitrozole
P
P01AX08 Tenonitrozole
[P01AX] Other agents against amoebiasis and other protozoal diseases
[P01A] AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
[P01] ANTIPROTOZOALS
[P] Antiparasitic products, insecticides and repellents
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 0.73±0.12 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 0.56 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 0.68±0.45 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
   |
Danger |
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal] H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] |
P261, P264, P270, P272, P280, P285, P301+P310, P302+P352, P304+P341, P312, P321, P322, P330, P333+P313, P342+P311, P363, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 2-(alpha-Thenoylamino)-2-nitro-5-thiazole | 2-Thiophenecarboxamide, N-(5-nitro-2-thiazolyl)- | 3810-35-3 |
| 6N-021 | AKOS003277664 | Atricam |
| Atrican (TN) | Atrican 109 | BRD-K93862950-001-07-1 |
| BRN 0247925 | C8H5N3O3S2 | CAS-3810-35-3 |
| CHEBI:135042 | CHEMBL1082354 | D07360 |
| DB13659 | DSSTox_CID_26277 | DSSTox_GSID_46277 |
| DSSTox_RID_81504 | DTXSID5046277 | EINECS 223-282-9 |
| HMS2233B18 | HMS3370N03 | KS-00001YKI |
| LS-152967 | MCULE-6457622214 | MLS001240199 |
| Moniflagon | N-(5-Nitro-2-thiazolyl)-2-thiophenecarboxamide | N-(5-Nitrothiazol-2-yl)thiophene-2-carboxamide |
| N-(5-nitro(1,3-thiazol-2-yl))-2-thienylcarboxamide | N-(5-nitro-1,3-thiazol-2-yl)-2-thiophenecarboxamide; | N-(5-nitro-1,3-thiazol-2-yl)thiophene-2-carboxamide |
| NCGC00160655-01 | NCGC00160655-02 | NCGC00160655-03 |
| Neo-trichocid | PBQ7WLE1WP | Q7700556 |
| REGID_for_CID_19646 | SCHEMBL150446 | SMR000674575 |
| SR-01000213288 | SR-01000213288-1 | SR-01000213288-5 |
| ST50236207 | STK071581 | TC 109 |
| TC-109 | TENONITROZOLE | Tenonitrozol |
| Tenonitrozol [INN-Spanish] | Tenonitrozole (INN) | Tenonitrozole [INN] |
| Tenonitrozolum | Tenonitrozolum [INN-Latin] | Thenitrazol |
| Thiophene-2-carboxylic acid (5-nitro-thiazol-2-yl)-amide | Tox21_111962 | Tox21_111962_1 |
| Tricosept | UNII-PBQ7WLE1WP | ZINC4217523 |
| alpha-Thenoylamino-2-nitro-5-thiazole | alpha-Thenoylamino-2-nitro-5-thiazole [French] |